Iovance Biotherapeutics Stock Market Value
| IOVA Stock | USD 11.31 0.41 3.50% |
| Symbol | Iovance |
Iovance Biotherapeutics Price To Book Ratio
Is Iovance Biotherapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Iovance Biotherapeutics. If investors know Iovance will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Iovance Biotherapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.89) | Revenue Per Share 0.005 | Return On Assets (0.40) | Return On Equity (0.82) |
The market value of Iovance Biotherapeutics is measured differently than its book value, which is the value of Iovance that is recorded on the company's balance sheet. Investors also form their own opinion of Iovance Biotherapeutics' value that differs from its market value or its book value, called intrinsic value, which is Iovance Biotherapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Iovance Biotherapeutics' market value can be influenced by many factors that don't directly affect Iovance Biotherapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Iovance Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Iovance Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Iovance Biotherapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Iovance Biotherapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Iovance Biotherapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Iovance Biotherapeutics.
| 05/01/2022 |
| 04/20/2024 |
If you would invest 0.00 in Iovance Biotherapeutics on May 1, 2022 and sell it all today you would earn a total of 0.00 from holding Iovance Biotherapeutics or generate 0.0% return on investment in Iovance Biotherapeutics over 720 days. Iovance Biotherapeutics is related to or competes with PTC Therapeutics, Krystal Biotech, Sarepta Therapeutics, Madrigal Pharmaceuticals, CureVac NV, Apellis Pharmaceuticals, and Ocean Biomedical. Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer ... More
Iovance Biotherapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Iovance Biotherapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Iovance Biotherapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.75 | |||
| Information Ratio | 0.0938 | |||
| Maximum Drawdown | 40.2 | |||
| Value At Risk | (6.29) | |||
| Potential Upside | 8.39 |
Iovance Biotherapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Iovance Biotherapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Iovance Biotherapeutics' standard deviation. In reality, there are many statistical measures that can use Iovance Biotherapeutics historical prices to predict the future Iovance Biotherapeutics' volatility.| Risk Adjusted Performance | 0.0742 | |||
| Jensen Alpha | 0.4931 | |||
| Total Risk Alpha | (0.12) | |||
| Sortino Ratio | 0.1692 | |||
| Treynor Ratio | 0.2472 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Iovance Biotherapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Iovance Biotherapeutics Backtested Returns
Iovance Biotherapeutics appears to be slightly risky, given 3 months investment horizon. Iovance Biotherapeutics holds Efficiency (Sharpe) Ratio of 0.11, which attests that the entity had a 0.11% return per unit of risk over the last 3 months. By evaluating Iovance Biotherapeutics' technical indicators, you can evaluate if the expected return of 0.74% is justified by implied risk. Please utilize Iovance Biotherapeutics' Risk Adjusted Performance of 0.0742, market risk adjusted performance of 0.2572, and Downside Deviation of 3.75 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Iovance Biotherapeutics holds a performance score of 8. The company retains a Market Volatility (i.e., Beta) of 2.87, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Iovance Biotherapeutics will likely underperform. Please check Iovance Biotherapeutics' expected short fall, and the relationship between the value at risk and daily balance of power , to make a quick decision on whether Iovance Biotherapeutics' current trending patterns will revert.
Auto-correlation | -0.41 |
Modest reverse predictability
Iovance Biotherapeutics has modest reverse predictability. Overlapping area represents the amount of predictability between Iovance Biotherapeutics time series from 1st of May 2022 to 26th of April 2023 and 26th of April 2023 to 20th of April 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Iovance Biotherapeutics price movement. The serial correlation of -0.41 indicates that just about 41.0% of current Iovance Biotherapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.41 | |
| Spearman Rank Test | -0.35 | |
| Residual Average | 0.0 | |
| Price Variance | 11.44 |
Iovance Biotherapeutics lagged returns against current returns
Autocorrelation, which is Iovance Biotherapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Iovance Biotherapeutics' stock expected returns. We can calculate the autocorrelation of Iovance Biotherapeutics returns to help us make a trade decision. For example, suppose you find that Iovance Biotherapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Iovance Biotherapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Iovance Biotherapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Iovance Biotherapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Iovance Biotherapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Iovance Biotherapeutics Lagged Returns
When evaluating Iovance Biotherapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Iovance Biotherapeutics stock have on its future price. Iovance Biotherapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Iovance Biotherapeutics autocorrelation shows the relationship between Iovance Biotherapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Iovance Biotherapeutics.
Regressed Prices |
| Timeline |
Iovance Biotherapeutics Investors Sentiment
The influence of Iovance Biotherapeutics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Iovance. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Iovance Biotherapeutics' public news can be used to forecast risks associated with an investment in Iovance. The trend in average sentiment can be used to explain how an investor holding Iovance can time the market purely based on public headlines and social activities around Iovance Biotherapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Iovance Biotherapeutics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Iovance Biotherapeutics' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Iovance Biotherapeutics' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Iovance Biotherapeutics.
Iovance Biotherapeutics Implied Volatility | 76.62 |
Iovance Biotherapeutics' implied volatility exposes the market's sentiment of Iovance Biotherapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Iovance Biotherapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Iovance Biotherapeutics stock will not fluctuate a lot when Iovance Biotherapeutics' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Iovance Biotherapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Iovance Biotherapeutics' short interest history, or implied volatility extrapolated from Iovance Biotherapeutics options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Iovance Biotherapeutics Correlation, Iovance Biotherapeutics Volatility and Iovance Biotherapeutics Alpha and Beta module to complement your research on Iovance Biotherapeutics. For information on how to trade Iovance Stock refer to our How to Trade Iovance Stock guide.You can also try the AI Investment Finder module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Iovance Stock analysis
When running Iovance Biotherapeutics' price analysis, check to measure Iovance Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Iovance Biotherapeutics is operating at the current time. Most of Iovance Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Iovance Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Iovance Biotherapeutics' price. Additionally, you may evaluate how the addition of Iovance Biotherapeutics to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |
Iovance Biotherapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.